Article

Chase finalizes Unicorn acquisition, expands line

Wilmington, DE-Chase Card Services, a division of JPMorgan Chase & Co., has finalized the acquisition of Unicorn Financial Services, a financing company for health-care patients.

Wilmington, DE-Chase Card Services, a division of JPMorgan Chase & Co., has finalized the acquisition of Unicorn Financial Services, a financing company for health-care patients. The combined company officially has launched its expanded set of patient financing products as ChaseHealthAdvance financing options.

Increasing medical and dental costs have created a need for new and adaptive health-care financing options, according to the company. In addition, the demand for elective procedures-dental, vision correction, and cosmetic, as well as veterinary care for pets-is increasing rapidly.

“Chase is able to offer affordable, flexible options for those looking to finance health-care procedures, as well as provide competitive service fees for providers,” said Hugh Bleemer, general manager, ChaseHealthAdvance.

Among the offerings to physicians and patients are no-interest and extended payment plans, as well as credit lines for current and future procedures, according to the company. In addition, medical practitioners will have access to all of Chase’s financial products, including business banking, real estate financing, equipment leasing, cash management, credit card processing, and loan products.

For more information on ChaseHealthAdvance financing options, visit www.chasehealthadvance.com.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.